28 . 09 .2021
Press release
Galderma to unveil ground-breaking data from across its leading dermatology portfolio and showcase major update for sensitive skincare brand CETAPHIL® at the 2021 EADV Congress
27 . 09 .2021
Press release
Galderma and CETAPHIL® Announce Renewed Commitment to Environmental Sustainability and Social Impact Through New Clear Skies Initiative
23 . 09 .2021
Press release
Galderma announces exclusive agreement with Sofregen to develop the next generation of biostimulator fillers using silk-based technology
09 . 09 .2021
Press release
Galderma to present new data from leading aesthetics portfolio and launch RESTYLANE® EYELIGHT™ at AMWC 2021
28 . 06 .2021
Press release
Sol-Gel Technologies and Galderma announce exclusive licenses for the commercialization of EPSOLAY® and TWYNEO® in the United States
11 . 06 .2021
Press release
Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe
19 . 05 .2021
Press release
How Galderma's Environmental, Social and corporate Governance approach guides its roadmap for sustainable growth
11 . 05 .2021
Press release
Galderma launches CETAPHIL® line for sensitive skin and a new DAYLONG® sun protection product in Switzerland
04 . 05 .2021
Press release
Galderma launches new Multichannel Medical Education platform: Inaugural webinar series on the impact of mask wearing on skin diseases